Independent Advisor Alliance Grows Holdings in Agilent Technologies, Inc. $A

Independent Advisor Alliance lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 215.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,954 shares of the medical research company’s stock after buying an additional 5,432 shares during the quarter. Independent Advisor Alliance’s holdings in Agilent Technologies were worth $1,082,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Flynn Zito Capital Management LLC grew its position in shares of Agilent Technologies by 3.2% in the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after buying an additional 69 shares during the period. Gabelli Funds LLC grew its position in shares of Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after buying an additional 74 shares during the period. Fiduciary Trust Co grew its position in shares of Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares during the period. NorthCrest Asset Manangement LLC grew its position in shares of Agilent Technologies by 1.6% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after buying an additional 79 shares during the period. Finally, Freestone Capital Holdings LLC grew its position in shares of Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after buying an additional 84 shares during the period.

Agilent Technologies Stock Down 1.4%

Shares of Agilent Technologies stock opened at $111.69 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The stock has a market capitalization of $31.56 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 2.38 and a beta of 1.22. Agilent Technologies, Inc. has a 52-week low of $107.07 and a 52-week high of $160.27. The company has a 50-day simple moving average of $115.06 and a two-hundred day simple moving average of $130.68.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The firm had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A has been the topic of a number of recent research reports. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Morgan Stanley cut their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. TD Cowen reduced their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price for the company. Finally, Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.